However, a meta-analysis on patients with type 2 diabetes mellitus using DPP-4 inhibitors revealed no association between their use and pancreatitis (Mantel–Haenszel odds ratio with a 95% confidence interval: 0.93 [0.51–1.69]; p = 0.82) [111]. This evidence concerns the gene DPP4 and pancreatitis.